Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Expert Opin Investig Drugs ; 15(12): 1523-35, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17107278

RESUMEN

Being highly pathogenic for human and nonhuman primates and the subject of former weapon programmes makes Ebola virus one of the most feared pathogens worldwide today. Due to a lack of licensed pre- and postexposure intervention, the current response depends on rapid diagnostics, proper isolation procedures and supportive care of case patients. Consequently, the development of more specific countermeasures is of high priority for the preparedness of many nations. Over the past years, enhanced research efforts directed to better understand virus replication and pathogenesis have identified potential new targets for intervention strategies. The authors discuss the most promising therapeutic approaches for Ebola haemorrhagic fever as judged by their efficacy in animal models. The current development in this field encourages discussions on how to move some of the experimental approaches towards clinical application.


Asunto(s)
Antivirales/uso terapéutico , Productos Biológicos/uso terapéutico , Fiebre Hemorrágica Ebola/terapia , Animales , Antivirales/farmacología , Evaluación Preclínica de Medicamentos , Vacunas contra el Virus del Ébola , Ebolavirus/clasificación , Ebolavirus/efectos de los fármacos , Ebolavirus/patogenicidad , Ebolavirus/fisiología , Fiebre Hemorrágica Ebola/tratamiento farmacológico , Fiebre Hemorrágica Ebola/inmunología , Fiebre Hemorrágica Ebola/fisiopatología , Fiebre Hemorrágica Ebola/virología , Humanos , Sueros Inmunes , Inmunización Pasiva , Primates , Roedores , Proteínas Virales/fisiología , Replicación Viral/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA